Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 2/20 | 0.39 |
| ▸ | RAB9A | P51151 | 2/20 | 0.39 |
| ▸ | CNR1 | P21554 | 2/20 | 0.39 |
| ▸ | CNR2 | P34972 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 3/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2909713 | 0.96 | CNR1 (0.39) | NPC1RAB9ACNR1CNR2MEN1 | |
| SCHEMBL2912956 | 0.96 | CNR1 (0.39) | NPC1RAB9ACNR1CNR2MEN1 | |
| SCHEMBL2914533 | 0.85 | SMN1; SMN2 (0.39) | NPC1RAB9ACNR1CNR2MEN1 | |
| SCHEMBL2913981 | 0.85 | ALDH1A1 (0.46) | NPC1RAB9AMEN1KMT2AEPHX2 | |
| SCHEMBL2912667 | 0.85 | ALDH1A1 (0.46) | NPC1RAB9AMEN1KMT2AEPHX2 | |
| SCHEMBL2909861 | 0.84 | SMN1; SMN2 (0.38) | NPC1RAB9ACNR1CNR2MEN1 | |
| SCHEMBL2912870 | 0.83 | ALDH1A1 (0.43) | NPC1RAB9ACNR1CNR2MEN1 | |
| SCHEMBL2913142 | 0.83 | ALDH1A1 (0.43) | NPC1RAB9ACNR1CNR2MEN1 | |
| SCHEMBL2912649 | 0.81 | KMT2A (0.39) | NPC1RAB9AMEN1KMT2AEPHX2 | |
| SCHEMBL2908003 | 0.81 | KMT2A (0.39) | NPC1RAB9AMEN1KMT2AEPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2222645-A2 | BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS | F. Hoffmann-La Roche AG (CH) | 2010-09-01 | — | — | EP | claimed |
| WO-2009062874-A2 | BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS | F. HOFFMANN-LA ROCHE AG (CH) | 2009-05-22 | — | — | WO | claimed |
| EP-2222645-A2 | BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS | F. Hoffmann-La Roche AG (CH) | 2010-09-01 | — | — | EP | disclosed |
| WO-2009062874-A2 | BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS | F. HOFFMANN-LA ROCHE AG (CH) | 2009-05-22 | — | — | WO | disclosed |